The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

PDF) Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab

Design, synthesis, and biological evalution of bifunctional

HSP90 inhibitors induce GPNMB cell-surface expression by

Following the design path of isoform-selective Hsp90 inhibitors

Biomolecules, Free Full-Text

PDF) In Silico Discovery and Optimisation of a Novel Structural

Characterization of p95HER2/611CTF-positive breast cancers and

PDF) A novel HSP90 inhibitor targeting the C-terminal domain

New ruthenium-xanthoxylin complex eliminates colorectal cancer

Biomolecules, Free Full-Text

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

Cancers, Free Full-Text

Salinomycin suppresses cell viability. TNBC cell lines [(A) MDA-MB

A novel HSP90 inhibitor SL-145 suppresses metastatic triple